Intuit to Cut 17 of Workforce Amid AI Focus Shares Sink 42 in 2026
In China Middlemen Exploit Legal Gaps to Sustain Crypto Trading Amid Crackdown
Morgan Stanley and Argus Research Reduce ADP Price Targets After Earnings Review
Gold Slides as Feds Waller Signals Potential Rate Hike Amid Iran Crisis
Jim Cramer Discusses Stock Picks and Potential Upside in Latest Investing Club Meeting
South Koreas Deputy PM Warns AI Could Worsen Wealth Inequality Amid Samsung Labor Disputes
ADBE Q1 2026 Earnings EPS Surpasses Expectations by 117
Monopar Therapeutics Q1 2026 Earnings Narrower Loss Surprises Market
RCEL Q1 2026 Earnings EPS Misses Estimates Stock Gains Amid Operational Progress
ABVX Q4 2025 Earnings WiderThanExpected Loss Highlights ClinicalStage Biotech Challenges
WGS Q1 2026 Earnings Significant EPS Miss Highlights Operational Challenges
SHLS Q1 2026 Earnings EPS Beats Estimates by 10 Amid Strong Operational Performance
John Hancock Preferred Income Fund HPI Holds Steady Near 1606 as Key Support and Resistance Levels Define Potential Path
BBU Brookfield Business Partners Stock Slides as Bearish Momentum Persists
Neuberger Real Estate Securities Income Fund NRO Holds Steady Near 300 Amid Modest Gains
Hanmi Financial HAFC Edges Lower Amid Broader Banking Sector Weakness
Nayax Ltd NYAX Gains 184 as Stock Approaches Key Resistance at 7946
Barclays Reports 18 Profit Rise Lifts FullYear Income Guidance
Ameren Corporation AEE Q1 2026 Earnings EPS Surges Past Expectations as Utility Operations Drive Steady Performance
Greenland Mines Ltd GRML Holds Near Support at 037 After Modest Gain
IRIDEX Corporation IRIX Holds Steady at 101 as Key Support and Resistance Levels Tighten
JFrog FROG Shows Resilience with 153 Gain as Stock Tests Key Resistance Zone
RenovoRx Inc RNXT Hovers Near Support as Thin Trading Persists
MUZE Holds Steady Near Midpoint of Range
Oric Pharmaceuticals ORIC Holds Steady Near Key Support Levels Amidst Modest Gains
Energy Focus Inc EFOI Edges Higher Amid Consolidation Near Support Levels
Filana Therapeutics FLNA Posts Modest Gains Amid Broader Biotech Resilience